CN103142977A - Medicament for treating dysmenorrhea - Google Patents
Medicament for treating dysmenorrhea Download PDFInfo
- Publication number
- CN103142977A CN103142977A CN 201310108671 CN201310108671A CN103142977A CN 103142977 A CN103142977 A CN 103142977A CN 201310108671 CN201310108671 CN 201310108671 CN 201310108671 A CN201310108671 A CN 201310108671A CN 103142977 A CN103142977 A CN 103142977A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- medicament
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating dysmenorrhea. The medicament is prepared from the following substances in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of goldthread, 5-15 parts of chrysanthemum, 10-30 parts of lophatherum gracile, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of root of kudzu vine, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of fructus perillae, 1-20 parts of radix bupleuri, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of cassia twig, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of cortex periplocae, 15-25 parts of root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All components of the medicament for treating dysmenorrhea disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of dysmenorrhea.
Background technology
Dysmenorrhea refers to that the women in menstrual period and front and back thereof, lower abdomen or flank pain occur, even pain and waist sacrum.Often send out with menstrual cycle, severe patient can be accompanied nausea and vomiting, dripping cold sweat, deadly cold hand and foot, even faints, and brings impact for work and life.Present clinical two kinds of constitutional and the Secondary cases that often it are divided into, primary dysmenorrhea refer to that the genitals without obvious pathological changes person, therefore claim again primary dysmenorrhea, is more common in adolescence, the unmarried and married person of not educating more.Many can the alleviation or disappear of this kind dysmenorrhea pain after normal labor.Secondary dysmenorrhea is many to be had due to organic disease because of the genitals.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of dysmenorrhea.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of dysmenorrhea, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Lophatheri 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Puerariae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Perillae 10-30 part, Radix Bupleuri 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Ramulus Cinnamomi 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Cortex Periplocae 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, the medicament for the treatment of dysmenorrhea of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Lophatheris, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Radix Puerariaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Perillaes, 16 parts of Radix Bupleuri, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Ramulus Cinnamomi, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Cortex Periplocaes, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of dysmenorrhea of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Lophatheri 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Radix Puerariae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Perillae 21 grams, Radix Bupleuri 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Ramulus Cinnamomi 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Cortex Periplocae 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rhododendri Mollis 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria is made a definite diagnosis with reference to the diagnostic criteria in " Gynecology of Chinese Medicine ".Periodically lower abdomen pain appears in the women before and after menstrual period or menstrual period, pain is drawn the waist energy, and even severe pain causes the person of fainting, and with other discomforts, so that affect work and life.Married women is through gynecologial examination, and unmarried female is through B-mode ultrasonography, all get rid of genitals's organic disease (the Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying) [S]. Beijing: Chinese Medicine science and technology publishing house, 2002:168.).According to " new Chinese medicine guideline of clinical investigations " dysmenorrhea degree divide gently, in, weigh 3 grades (Ministry of Health of the People's Republic of China. new Chinese medicine guideline of clinical investigations: the 1st volume of [S] .1993:252.).
Choose 60 examples that meet above-mentioned standard, unmarried 46 examples, married 14 examples; Minimum 12 years old of age, maximum 24 years old; The course of disease 3 months-6 years.
Therapeutic scheme
Decoction with preparation in embodiment 1 is treated.Take each 20 milliliters every day 2 times.2 weeks were 1 course for the treatment of.
Criterion of therapeutical effect
By dysmenorrhea clinical index integration, with the state of an illness be divided into gently (＜8 minutes), in (8-13.5 divides), weight (〉=13.5 minutes).Medication was passed judgment on after 1 course for the treatment of.Recovery from illness: stomachache and other transference cures, 3 menstrual cycle of drug withdrawal do not recur, and dysmenorrhea clinical symptoms integration is 0; Produce effects: stomachache obviously alleviates, and other transference cures or alleviate refuse to obey that analgesic can adhere to work, 1/2 of the front integration of dysmenorrhea clinical symptoms integration≤treatment; Effectively: stomachache alleviates, and other symptoms take a turn for the better, and takes analgesic and can adhere to work, 1/3 of the front integration of dysmenorrhea clinical symptoms integration≤treatment; Invalid: stomachache and other symptoms without change (Ministry of Health of the People's Republic of China. new Chinese medicine guideline of clinical investigations: the 1st volume of [S] .1993:252.).
Treat the result after a course for the treatment of:
All patients all meet the treatment standard of recovery from illness, and do not observe obvious untoward reaction in therapeutic process.
Claims (3)
1. medicament for the treatment of dysmenorrhea, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Lophatheri 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Radix Puerariae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Perillae 10-30 part, Radix Bupleuri 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Ramulus Cinnamomi 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Cortex Periplocae 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of dysmenorrhea according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Lophatheris, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Radix Puerariaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Perillaes, 16 parts of Radix Bupleuri, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Ramulus Cinnamomi, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Cortex Periplocaes, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
3. the medicament for the treatment of dysmenorrhea according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310108671 CN103142977A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating dysmenorrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310108671 CN103142977A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating dysmenorrhea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103142977A true CN103142977A (en) | 2013-06-12 |
Family
ID=48541486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310108671 Pending CN103142977A (en) | 2013-03-22 | 2013-03-22 | Medicament for treating dysmenorrhea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142977A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998346A (en) * | 2015-07-30 | 2015-10-28 | 宁波好口味食品有限公司 | Belt for treating dysmenorrhea and preparation method thereof |
-
2013
- 2013-03-22 CN CN 201310108671 patent/CN103142977A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998346A (en) * | 2015-07-30 | 2015-10-28 | 宁波好口味食品有限公司 | Belt for treating dysmenorrhea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN103142987B (en) | Medicament for treating mumps | |
| CN102872309A (en) | Chinese medicine formulation of climacteric mind tranquilizing drug for treating climacteric syndrome and dysfunction of autonomic nervous system | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN103142981A (en) | Medicament for treating mammitis | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN103191385B (en) | Medicament for treating infantile asthma | |
| CN102488797B (en) | Medicinal composition for treating dysmenorrhea | |
| CN103157084A (en) | Drug for treating osteoporosis | |
| CN103272192B (en) | Medicament for treating perianal abscess | |
| CN103550516B (en) | A kind of preparation method for the treatment of the medicament of perianal abscess | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN103157093A (en) | Drug for treating insomnia | |
| CN102366611B (en) | Traditional Chinese medicine lavipeditum composition for treating hypertension | |
| CN103041346A (en) | Decoction for treating dysmenorrhea | |
| CN103142973B (en) | Medicament for treating neurasthenia | |
| CN101049346A (en) | Medication for treating rhinitis and tympanitis, and preparation method | |
| CN103157085A (en) | Drug for treating fracture | |
| CN103157083A (en) | Medicament for treating premature beat | |
| CN103816272B (en) | Method for preparing medicine treating intercondylar fracture of humerus | |
| CN104306457A (en) | Injection liquid for treating epidemic cerebrospinal meningitis and preparation method thereof | |
| CN103203007B (en) | Medicament used for treating bedsore in clinical care | |
| CN103191397B (en) | Medicament for treating xerophthalmia of information staff in hospitals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130612 |